Literature DB >> 27296131

Hippo Signaling in the Heart - Non-Canonical Pathways Impact Growth, Survival and Function.

Dominic P Del Re1.   

Abstract

Initially identified inDrosophila melanogaster, the Hippo signaling pathway regulates organ size through modulation of cell proliferation, survival and differentiation. This pathway is evolutionarily conserved and canonical signaling involves a kinase cascade that phosphorylates and inhibits the downstream effector Yes-associated protein (YAP). Recent research has demonstrated a fundamental role of Hippo signaling in cardiac development, homeostasis, injury and regeneration, and remains the subject of intense investigation. However, 2 prominent members of this pathway, RASSF1A and Mst1, have been shown to influence heart function and stress responses through YAP-independent mechanisms. This review summarizes non-canonical targets of RASSF1A and Mst1 and discusses their role in the context of cardiac hypertrophy, autophagy, apoptosis and function. (Circ J 2016; 80: 1504-1510).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27296131     DOI: 10.1253/circj.CJ-16-0426

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

1.  Aerobic Training-induced Upregulation of YAP1 and Prevention of Cardiac Pathological Hypertrophy in Male Rats.

Authors:  Arezoo Tabrizi; Rahman Soori; Siroos Choobineh; Majid Gholipour
Journal:  Int J Prev Med       Date:  2020-08-06

2.  Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes.

Authors:  Hideki Yasutake; Jong-Kook Lee; Akihito Hashimoto; Kiyoshi Masuyama; Jun Li; Yuki Kuramoto; Shuichiro Higo; Shungo Hikoso; Kyoko Hidaka; Atsuhiko T Naito; Shigeru Miyagawa; Yoshiki Sawa; Issei Komuro; Yasushi Sakata
Journal:  Sci Rep       Date:  2021-05-14       Impact factor: 4.379

Review 3.  How Hippo Signaling Pathway Modulates Cardiovascular Development and Diseases.

Authors:  Wenyi Zhou; Mingyi Zhao
Journal:  J Immunol Res       Date:  2018-02-08       Impact factor: 4.818

4.  RASSF1A Enhances Chemosensitivity of NSCLC Cells Through Activating Autophagy by Regulating MAP1S to Inactivate Keap1-Nrf2 Pathway.

Authors:  Jincai Wang; Xufeng Zhang; Fang Yang; Yuguang Yang; Tianjiao Wang; Wenming Liu; Hongfeng Zhou; Wei Zhao
Journal:  Drug Des Devel Ther       Date:  2021-01-06       Impact factor: 4.162

Review 5.  Evidence for the Benefits of Melatonin in Cardiovascular Disease.

Authors:  Mohammad Tobeiha; Ameneh Jafari; Sara Fadaei; Seyed Mohammad Ali Mirazimi; Fatemeh Dashti; Atefeh Amiri; Haroon Khan; Zatollah Asemi; Russel J Reiter; Michael R Hamblin; Hamed Mirzaei
Journal:  Front Cardiovasc Med       Date:  2022-06-20

6.  Melatonin attenuates doxorubicin-induced cardiotoxicity through preservation of YAP expression.

Authors:  Hai-Ru Li; Chao Wang; Ping Sun; Dan-Dan Liu; Guo-Qing Du; Jia-Wei Tian
Journal:  J Cell Mol Med       Date:  2020-02-18       Impact factor: 5.310

Review 7.  Molecular Signaling to Preserve Mitochondrial Integrity against Ischemic Stress in the Heart: Rescue or Remove Mitochondria in Danger.

Authors:  Justin D Yu; Shigeki Miyamoto
Journal:  Cells       Date:  2021-11-27       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.